KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Resmed (RMD) Non-cash Items (2016 - 2021)

Resmed (RMD) has disclosed Non-cash Items for 11 consecutive years, with $158.5 million as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Non-cash Items rose 44.09% year-over-year to $158.5 million, compared with a TTM value of $158.5 million through Jun 2021, up 44.09%, and an annual FY2021 reading of $158.5 million, up 44.09% over the prior year.
  • Non-cash Items was $158.5 million for Q2 2021 at Resmed, up from $110.0 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $238.4 million in Q2 2019 and bottomed at $110.0 million in Q2 2020.
  • Average Non-cash Items over 5 years is $184.5 million, with a median of $188.8 million recorded in 2017.
  • The sharpest move saw Non-cash Items tumbled 53.86% in 2020, then surged 44.09% in 2021.
  • Year by year, Non-cash Items stood at $194.5 million in 2017, then increased by 14.29% to $222.3 million in 2018, then grew by 7.24% to $238.4 million in 2019, then crashed by 53.86% to $110.0 million in 2020, then soared by 44.09% to $158.5 million in 2021.
  • Business Quant data shows Non-cash Items for RMD at $158.5 million in Q2 2021, $110.0 million in Q2 2020, and $238.4 million in Q2 2019.